Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy

Journal of Neurology

Volumn 242, Issue 4, 1995, Pages 252-253

  Choudhary, P P ^a   Thompson, N ^a   Hughes, R A C ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; IMMUNOGLOBULIN; PREDNISOLONE; RECOMBINANT BETA INTERFERON;

ADOLESCENT; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; DEMYELINATING DISEASE; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PLASMAPHERESIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD;

CASE REPORT; CHILD; CHRONIC DISEASE; DEMYELINATING DISEASES; FEMALE; HUMAN; INTERFERON-BETA; POLYNEUROPATHIES; RECOMBINANT PROTEINS;

EID: 0028953855     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/BF00919601     Document Type: Article

References (5)

1. Interferon beta in multiple sclerosis
2. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
3. Interferon β decreases T cell activation and interferon gamma production in multiple sclerosis
4. The role of interferongamma in the pathogenesis of experimental disease of the peripheral nervous system
5. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy